All site RSS
The review of Russian Biotech industry
Pharma Executive The review of Russian Biotech industry and most important players in the beginning of 2014.
From vision to decision
PWC PwC vision of Pharma 2020 pillars. The description of 3 fundamental challenges: rising customer expectation, poor scientific productivity, cultural sclerosis.
Site Selection for Life Sciences Companies
KPMG in association with Venture Valuation This analysis is aimed at helping entrepreneurs to choose the best possible spot to set up Biotechnology business in EU. The report compares leading EU Life Science...
Bioscience Economic Development: Legislative Priorities, Best Practices, and Return on Investment
BIO - Biotechnology Industry Organization This report by BIO is a digest of noteworthy public policy strategies and programs to assist policy leaders and their bioscience industry partners in identifying...
outh Korea Life Sciences Trend Analysis 2015
Venture Valuation The analysis of life sciences indusrty in South Korea in 2015. The report discusses key activities, ownership type, financing raised, therapeutic products in the Pipeline of Korea Biotech...
Pharma Executive 2014-01 Russian Biotech
Офисы и лаборатории
Skolkovo Institute of Science and Technology
Customs and Finance Company
Intellectual property centre
© 2023 Skolkovo Foundation